Stocks/SUPN

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

SUPN

↓ PDF (Pro)
Supernus Pharmaceuticals Inc. Common Stock
HealthcareDrug Manufacturers - Specialty & GenericNASDAQ
$48.59
-0.08%today
MKT CAP
$3.0B
-3.3% · 1Y
Full Financials
Trailing P/E-
Forward P/E11.5x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership-
Institutional Ownership-
Short % of Float-
Days to Cover-
1 Week+0.5%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PBH
Prestige Consumer Healthcare Inc. Common Stock
$2.5B8014.311.3----0.00%
LQDA
Liquidia Corporation Common Stock
$3.7B63-8.1--111.1%92%442.310.00%
PAHC
Phibro Animal Health Corporation Class A Common Stock
$2.3B5119.112.7----82.00%
HCM
HUTCHMED (China) Limited American Depositary Shares
$2.3B675.025.5----0.00%
BCRX
BioCryst Pharmaceuticals Inc. Common Stock
$2.3B80-11.7----0.00%
BHC
Bausch Health Companies Inc. Common Stock
$2.1B100-1.4----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total80
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for SUPN.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.